SBC Medical Group Holdings Inc
Close on Oct 19, 2026
- Market cap
- $549.81M
- P/E (TTM)
- 11.4
- Dividend yield
- –
About SBC Medical Group
Services-Offices & Clinics of Doctors of Medicine, SIC 8011
SBC Medical Group Holdings Incorporated operates as a healthcare services and clinic management holding company. Through its operating subsidiaries, the company provides support services to healthcare providers, which include medical corporations, franchisee clinics, and independent physicians. Its core business activities encompass management services, clinic franchising, procurement services, and equipment or facility rental services. The company primarily serves healthcare partners, medical corporations, and affiliated clinics that offer medical treatments, aesthetic healthcare, cosmetic surgery, and osteopathic care.
The company maintains business operations and clinic affiliations internationally, with activities and subsidiaries located across Japan, Singapore, Vietnam, and the United States. Its network includes medical corporations and independently operated clinics across these jurisdictions. SBC Medical Group Holdings Incorporated maintains its principal executive offices and corporate headquarters in Irvine, California.
Summary of the business section of SBC Medical Group's latest annual report, written by StockData.
Company profile
Company
- Legal name
- SBC Medical Group Holdings Inc
- Headquarters
- Irvine, CA
- Address
- 200 Spectrum Center Dr., Suite 300 92618
- Phone
- (949) 593-0250
- Employees
- 863, Dec 31, 2025
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- Incorporated in
- Delaware
- Fiscal year ends
- December 31
- Auditor
- MaloneBailey, LLP, Tokyo, Japan
Stock & identifiers
- Ticker
- SBC
- Other tickers
- SBCWW
- Exchange
- Nasdaq
- IPO date
- Aug 8, 2022
- Shares outstanding
- 103M, Jul 31, 2026
- Public float
- $48.20M, Jun 30, 2025
- Filer category
- Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
- SEC CIK
- 1930313
- CUSIP
- 73245B107
- ISIN
- US73245B1070
- EIN
- 88-1263511
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Yoshiyuki Aikawa | Chairman and CEO, Director | 83,839,460 |
| Miki Yamazaki | Chief Strategy Officer | – |
Employees
Headcount reported in annual reports
“As of December 31, 2025, we had approximately 863 regular employees globally (excluding employees of the managed clinics/medical corporations we support), a majority of which are located in Japan, Singapore, Vietnam, and the United States.”
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Jul 14, 2026 | Listing notice | Notice of delisting or failure to satisfy a listing rule (8-K Item 3.01) |
| Sep 20, 2024 | Auditor change | Change in certifying accountant (8-K Item 4.01) |
| Sep 20, 2024 | Acquisition / sale | Completion of acquisition or disposition of assets (8-K Item 2.01) |
| Sep 18, 2024 | Delisting | Notice of delisting from exchange (Form 25) |
| Aug 29, 2024 | Name change | Name changed from Pono Capital Two, Inc. to SBC Medical Group Holdings Inc |
| Aug 14, 2024 | Late filing | Notification of late filing |
| Aug 12, 2024 | Merger vote | Definitive merger proxy statement |
| May 15, 2024 | Late filing | Notification of late filing |
| May 8, 2024 | Listing notice | Notice of delisting or failure to satisfy a listing rule (8-K Item 3.01) |
| Apr 4, 2024 | Listing notice | Notice of delisting or failure to satisfy a listing rule (8-K Item 3.01) |
| Aug 8, 2022 | IPO | Initial public offering priced (424B4 prospectus) |
| Aug 2, 2022 | Listing | Registration of securities on an exchange (Form 8-A) |